How to choose a UK research peptide retailer

7-point retailer checklist

1. 1

   UK Companies House registration with active status

   A UK-incorporated company is legally required to file accounts and maintain an active status at Companies House. You can verify any company name or number for free at Companies House. Look for: active status (not dissolved, not struck off), a registered address that is not a virtual office shell, and a director record with verifiable identity. Retailers that operate only as an overseas-registered entity with no UK legal presence have no UK legal accountability.

2. 2

   Per-batch Certificate of Analysis from a named lab partner

   A Certificate of Analysis (CoA) is the primary document linking a specific batch of peptide to a specific set of analytical test results. The highest-trust CoA is: per-batch (not a one-time master certificate), issued by a named third-party laboratory (not the retailer's own in-house "testing"), and dated within the same calendar period as the batch was received. Retailers who name their laboratory partner (with a verifiable URL or company name) are more credible than those that simply state "third-party tested" without identification.

3. 3

   CoA accessibility: open download versus email-gated versus no access

   How a retailer gates its CoA documents is a proxy for its transparency posture. The most open model is a dedicated CoA subdomain or public URL where any batch certificate can be retrieved without an account. The middle model is email-on-request (you have to ask). The weakest model is image-only CoA embedded in product pages (not downloadable, not verifiable). Some retailers provide no CoA at all. PeptideClear's CoA Trust Index scores UK retailers on this axis.

4. 4

   HPLC purity verification and mass spectrometry for premium tier

   HPLC (high-performance liquid chromatography) measures the purity of the peptide by proportion: "99%+ HPLC" means the named compound makes up at least 99% of the total peptide content of the sample. It does not confirm the identity of the molecule, only its proportion. Mass spectrometry (MS) is a complementary test that identifies the molecule by molecular weight and fragmentation pattern. CoAs that include both HPLC and MS data are analytically stronger than HPLC alone. At the premium tier, some retailers also include amino acid analysis to confirm the complete sequence.

5. 5

   Endotoxin LAL testing for subcutaneous research applications

   Endotoxins are fragments of bacterial cell walls that can survive the peptide synthesis and lyophilisation process. In a research context where subcutaneous application is involved, endotoxin load matters. The standard test is the Limulus Amoebocyte Lysate (LAL) assay. Retailers who publish endotoxin data on their CoA documents are indicating a higher level of GMP-aligned quality control than those who do not. This is editorial commentary on what differentiates quality tiers, not a recommendation for any specific research application.

6. 6

   UK warehouse and dispatch versus grey import or international shipping

   Research peptides shipped from outside the UK may face HMRC customs inspection, MHRA border enforcement, or cold-chain interruption during transit. Retailers with a UK warehouse and domestic dispatch avoid these risks. If a retailer ships from China, the US, or Eastern Europe, ask specifically about their cold-chain packaging and customs documentation. Grey imports (product manufactured outside the UK without a UK import licence) carry a different regulatory risk profile than product sourced directly by a UK-registered operator under an import arrangement.

7. 7

   Verifiable trading history of more than three years

   The UK research peptide market has seen retailers launch, trade briefly, and close within 12 to 18 months. A retailer with more than three years of verifiable trading history (crosschecked via Companies House incorporation date, domain registration records, and Wayback Machine archive) has demonstrated some staying power. This does not guarantee quality, but it does mean the operator has maintained supply continuity across more than one product cycle. Operators with fewer than 12 months of visible history carry more counterparty risk.